Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Do Recommended Doses of β-lactams in ICU Patients on Continuous Renal Replacement Therapy (CRRT) Reach Therapeutic Concentrations ? — Lucie Seyler (2008) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Do Recommended Doses of β-lactams in ICU Patients on Continuous Renal Replacement Therapy (CRRT) Reach Therapeutic Concentrations ?
Shared by
Jean Louis Vincent
Université Libre de Bruxelles
Do Recommended Doses of β-lactams in ICU Patients on Continuous Renal Replacement Therapy (CRRT) Reach Therapeutic Concentrations ?
Article
2008
en
Authors
+5 more
LS
Lucie Seyler
FC
Frédéric Cotton
FT
Fabio Taccone
Abstract
1 min read
info:eu-repo/semantics/nonPublished
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2011
Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy
Cecilia Covajes
,
Daniel De Backer
,
Eva Ocampos-Martinez
,
Laura Penaccini
,
Ali Abdelhadii
,
Frédérique Jacobs
,
Jean Louis Vincent
,
Fabio Taccone
Article
2012
High Regimen of Continuous Infusion of Vancomycin During Continuous Renal Replacement Therapy
Marjorie Beumier
,
Hakim Kabtouri
,
Frédéric Cotton
,
Maya Hites
,
Jean Louis Vincent
,
Frédérique Jacobs
,
Fabio Taccone
Article
2010
Prevalence of continuous epileptiform discharges on EEG in patients treated with cefepime and meropenem
Gilles Naeije
,
Sophie Lorent
,
Jean Louis Vincent
,
Benjamin Legros
Article
2011
Broad spectrum beta-lactam serum levels are inadequate in most ICU patients
Maya Hites
,
Fabio Taccone
,
Sophie Lorent
,
Frédéric Cotton
,
Fleur Wolff
,
Rudy Surin
,
Jean Louis Vincent
,
Frédérique Jacobs
Article
2011
Enhanced sepsis-associated mortality of patients with cirrhosis in ICU: Results from the international EPIC II study
Thierry Gustot
,
Dimitrios Velissaris
,
Hassane Njimi
,
Fabio Taccone
,
Christophe Moreno
,
Jean Louis Vincent
Discussion(0)
No comments yet. Be the first to comment.